Differentially expressed genes in hepatocellular carcinoma induced by woodchuck hepatitis B virus in mice

World Journal of Gastroenterology

Volumn 7, Issue 4, 2001, Pages 575-578

  Cao, X Y ^a   Liu, J ^a   Lian, Z R ^a   Clayton, M ^a   Hu, J L ^a   Zhu, M H ^a   Fan, D M ^a   Feitelson, M ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RNA;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SEQUENCE; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMAGE SUBTRACTION; IN SITU HYBRIDIZATION; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER PARENCHYMA; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; VALIDATION PROCESS; VIROLOGY;

EID: 0034882659     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v7.i4.575     Document Type: Article

References (80)

1. Cloning and expression of core gene cDNA of Chinese hepatitis C virus in cosmid pTM3
2. Cloning of the non-structural gene 3 of hepatitis C virus and its inducible expression in cultured cells
3. Mutation of hepatitis B virus and its association with liver diseases
4. Cloning and expression of MXR7 gene in human HCC tissue
5. Appearance of an inhibitory cell nuclear antigen in rat and human serum during variable degrees of hepatic regenerative activity
6. Differential display and integrin alpha 6 messenger RNA overexpression in hepatocellular carcinoma
7. Differential gene expression in experimental hepatocellular carcinoma induced by woodchuck hepatitis B virus
8. Expression of heparin-binding epidermal growth factor in human hepatocellular carcinoma
9. Identification of a human hepatocellular carcinoma-associated tumor suppressor gene by differential display polymerase chain reaction
10. High frequency of the MAGE-1 gene expression in hepatocellular carcinoma
11. Expression of hepatocyte growth factor c-met proto-oncogene in hepatocellular carcinoma
12. Suppression subtractive hybridization: A method for generating differentially regulated or tissue specific cDNA probes and libraries
13. Identification of differentially expressed genes in HBxAg transfected HepG2 cells by suppression subtractive hybridization
14. Function of one novel gene identified by SSH PCR differentially expressed in HBx transfected HepG2 cells
15. Advances in clinical research of hepatocellular carcinoma in China
16. Gene therapy and liver diseases
17. Potential roles of tumor suppressor genes and microsatellite instability in hepatocellular carcinogenesis in southern African blacks
18. Prospect of gastroenterology and hepatology in the next century
19. Hepatocellular carcinoma in central Sydney: A 10-year review of patients seen in a medical oncology department
20. Immunological approaches to the breakdown of hepatitis B viral persistence
21. Susceptibility to hepatocellular carcinoma associated with null genotypes of GSTM1 and GSTT1
22. Characterization of six tumor suppressor genes and microsatellite instability in hepatocellular carcinoma in southern African blacks
23. Hepatic cell apoptosis and fas gene
24. Research and progress in vivo gene therapy for primary liver cancer
25. A comparison between previous and present histologic assessments of chronic hepatitis C viral infections in humans
26. Relationship between expression of α-fetoprotein messenger RNA and some clinical parameters of human hepatocellular carcinoma
27. Study of angiogenesis induced by metastatic and non-metastatic liver cancer by corneal micropocket model in nude mice
28. Gene expression of hepatocyte growth factor and its receptor in HCC and nontumorous liver tissues
29. Experimental study of bioartificial liver with cultured human-liver cells
30. Effects of endotoxin on expression of ras, p53 and bcl-2 oncoprotein in hepatocarcinogenesis induced by thioacetamide in rats
31. Reversing effect of Tanshinone on malignant phenotypes of human hepatocarcinoma cell line
32. In situ hybridization assay of androgen receptor gene in hepatocarcinogenesis
33. The effect of acupuncture on the IL2-IFN-NKC immunoregulatory system of mice with HAC grafting hepatocarcinoma
34. Study of angiogenesis induced by metastatic and non-metastatic liver cancer by corneal micropocket model in nude mice
35. 14+
36. The value of postoperative hepatic regional chemotherapy in prevention of recurrence after radical resection of primary liver cancer
37. Growth-inhibiting effects of taxol on human liver cancer in vitro and in nude mice
38. Gene expression profiles in liver cancer and normal liver tissues
39. Study on environmental etiology of high incidence areas of liver cancer in China
40. Expression of regulating apoptosis gene and apoptosis index in primary liver cancer
41. Traditional Chinese medicine in prevention of liver cancer
42. Inhibition of telomerase activity of human liver cancer cell SMMC-7721 by chemotherapeutic drugs
43. Experimental and clinical study on targeting treatment of liver cancer using radionuclide-anti-AFP antibody-MMC double bomb
44. Telomerase and primary liver cancer
45. Effect of p38MAPK signal pathway on ultrastructural change of liver cancer cells induced by VEGF
46. CSF-1 receptor/c-fms and liver cancer
47. Hepatocellular carcinoma: Recent progress
48. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis
49. Hepatitis B virus x antigen in the pathogenesis of chronic infections and development of hepatocellular carcinoma
50. The hepatitis B virus
51. Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat
52. A transactivator function is generated by integration of preS/S sequences in human hepatocellular carcinoma DNA
53. The preS/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator
54. The HBV X-ORF encodes a trans-activator: A potential factor in viral hepatocarcinogenesis
55. A trans-activating function encoded in the hepatitis B virus X gene is conserved in the integrated state
56. Integrated hepatitis B virus X and 3′ truncated preS/S sequence derived from human hepatomas encode functionally active transactivators
57. Malignant transformation of immortalized hepatocytes by hepatitis B virus DNA
58. In vitro tumorigenicity of hepatitis B virus DNA and HBx protein
59. HBX gene of hepatitis B virus induces liver cancer in transgenic mice
60. High level expression of hepatitis B virus HBx gene hepatocarcinogenesis in transgenic mice
61. Functional inactivation but not structural mutation of p53 causes liver cancer
62. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a ras, raf, MAP kinase signaling cascade
63. Induction of DNA-binding activity of c-Jun/c-Fos heterodimers by the hepatitis B virus transactivator pX
64. HBV HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases
65. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threoninie kinases
66. Hepatitis B virus HBX protein deregulates cell cycle checkpoint controls
67. Hepatitis B X antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma
68. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3
69. Direct interaction of hepatitis B virus HBX protein with p53 response element-directed transactivation
70. Hepatitis B virus transcriptional activators: Mechanism and possible role in oncogenesis
71. Increased expression of the insulin-like growth factor 1 (IGF-1) receptor gene in hepatocellular carcinoma cell lines: Implication of IGF-1 receptor gene activation by hepatitis B virus X gene product
72. Expression of the insulin-like growth factor 11 in hepatitis B, cirrhosis and hepatocellular carcinoma: Its relationship with hepatitis B virus antigen expression
73. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interaction
74. Hepatitis B virus transactivator protein X interacts with the TATA-binding protein
75. Human RPB5, a subunit shared by sukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation
76. The 17Kda HBX protein encoded by hepatitis B virus interacts with the activation domain of Oct-1, and functions as a coactivator in the activation and repression of a human U6 promoter
77. Proteasome complex as a potential cellular target of HBV X protein
78. The X protein of hepatitis B virus has a ribo-deoxy ATPase activity
79. Hepatitis B virus X protein is a potent AMP kinase
80. Hepatitis B virus transactivator HBx uses a tumor promoter signaling pathway